The HOPE study design tested the importance of interference with the renin-angiotensin-aldosterone system (RAAS) in reducing the subsequent cardiovascular event rate in high-risk patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback